Melanocytic nevi of eyelid, including canthus
ICD-10 D22.1 is a billable code used to indicate a diagnosis of melanocytic nevi of eyelid, including canthus.
Melanocytic nevi, commonly referred to as moles, are benign tumors of melanocytes, the pigment-producing cells in the skin. When located on the eyelid or canthus, these nevi can vary in appearance, size, and color. They are typically asymptomatic and may be present at birth or develop over time. While most melanocytic nevi are benign, they can occasionally undergo changes that warrant further evaluation to rule out malignancy. The eyelid region is particularly sensitive due to its anatomical structure and function, making the management of nevi in this area crucial. Treatment options may include observation, surgical excision, or laser therapy, depending on the size, location, and any associated symptoms. Regular follow-up is essential to monitor for any changes in the nevi, as well as to ensure proper healing post-treatment. The presence of melanocytic nevi in this area may also necessitate a multidisciplinary approach involving dermatology and ophthalmology for optimal patient care.
Detailed descriptions of the nevi, including size, color, and any changes over time.
Evaluation of new or changing nevi, management of symptomatic nevi.
Ensure clear documentation of benign nature and any treatment performed.
Assessment of visual function and any impact of nevi on eyelid movement.
Management of nevi affecting eyelid function or cosmetic appearance.
Collaboration with dermatology for comprehensive care.
Used when a melanocytic nevus is excised for cosmetic reasons.
Document size, location, and reason for excision.
Dermatology may require additional notes on the cosmetic outcome.
D22.1 specifically refers to melanocytic nevi located on the eyelid and canthus, while D22.0 refers to nevi located on the face. The distinction is important for accurate coding and treatment planning.
